Patents by Inventor Sonja van den Oudenrijn

Sonja van den Oudenrijn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Binding molecules for the treatment of myeloid cell malignancies
    Patent number: 8632985
    Abstract: Provided is a human C-type lectin, binding molecules that specifically bind to the human C-type lectin, nucleic acid molecules encoding the binding molecules or the human C-type lectin, compositions comprising the binding molecules or the human C-type lectin and methods of identifying or producing the binding molecules. The human C-type lectin is specifically expressed on myeloid cells and binding molecules capable of specifically binding to the human C-type lectin can be used in the diagnosis, prevention, and/or treatment of neoplastic disorders and diseases.
    Type: Grant
    Filed: May 17, 2012
    Date of Patent: January 21, 2014
    Assignee: Crucell Holland, B.V.
    Inventors: Sonja van den Oudenrijn, Marja van Meijer, Adrianns Q. Bakker, Alexander Berthold Hendrik Bakker
  • BINDING MOLECULES FOR THE TREATMENT OF MYELOID CELL MALIGNANCIES
    Publication number: 20120270802
    Abstract: Provided is a human C-type lectin, binding molecules that specifically bind to the human C-type lectin, nucleic acid molecules encoding the binding molecules or the human C-type lectin, compositions comprising the binding molecules or the human C-type lectin and methods of identifying or producing the binding molecules. The human C-type lectin is specifically expressed on myeloid cells and binding molecules capable of specifically binding to the human C-type lectin can be used in the diagnosis, prevention, and/or treatment of neoplastic disorders and diseases.
    Type: Application
    Filed: May 17, 2012
    Publication date: October 25, 2012
    Inventors: Sonja van den Oudenrijn, Marja van Meijer, Adrianns Q. Bakker, Alexander Berthold Hendrik Bakker
  • Binding molecules for the treatment of myeloid cell malignancies
    Patent number: 8268966
    Abstract: Provided is a human C-type lectin, binding molecules that specifically bind to the human C-type lectin, nucleic acid molecules encoding the binding molecules or the human C-type lectin, compositions comprising the binding molecules or the human C-type lectin and methods of identifying or producing the binding molecules. The human C-type lectin is specifically expressed on myeloid cells and binding molecules capable of specifically binding to the human C-type lectin can be used in the diagnosis, prevention and/or treatment of neoplastic disorders and diseases.
    Type: Grant
    Filed: December 18, 2009
    Date of Patent: September 18, 2012
    Assignee: Crucell Holland B.V.
    Inventors: Sonja van den Oudenrijn, Marja van Meijer, Adrianus Q. Bakker, Alexander Berthold Hendrik Bakker
  • Binding molecules for the treatment of myeloid cell malignancies
    Publication number: 20100184671
    Abstract: Provided is a human C-type lectin, binding molecules that specifically bind to the human C-type lectin, nucleic acid molecules encoding the binding molecules or the human C-type lectin, compositions comprising the binding molecules or the human C-type lectin and methods of identifying or producing the binding molecules. The human C-type lectin is specifically expressed on myeloid cells and binding molecules capable of specifically binding to the human C-type lectin can be used in the diagnosis, prevention and/or treatment of neoplastic disorders and diseases.
    Type: Application
    Filed: December 18, 2009
    Publication date: July 22, 2010
    Applicant: Crucell Holland B.V.
    Inventors: Sonja van den Oudenrijn, Marja van Meijer, Adrianus Q. Bakker, Alexander Berthold Hendrik Bakker
  • Binding molecules for the treatment of myeloid cell malignancies
    Patent number: 7741443
    Abstract: The present invention provides a human C-type lectin, binding molecules that specifically bind to the human C-type lectin, nucleic acid molecules encoding the binding molecules or the human C-type lectin, compositions comprising the binding molecules or the human C-type lectin and methods of identifying or producing the binding molecules. The human C-type lectin is specifically expressed on myeloid cells and binding molecules capable of specifically binding to the human C-type lectin can be used in the diagnosis, prevention and/or treatment of neoplastic disorders and diseases.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: June 22, 2010
    Assignee: Crucell Holland B.V.
    Inventors: Sonja van den Oudenrijn, Marja van Meijer, Adrianus Q. Bakker, Alexander Berthold Hendrik Bakker
  • Binding molecules for the treatment of myeloid cell malignancies
    Publication number: 20060177451
    Abstract: The present invention provides a human C-type lectin, binding molecules that specifically bind to the human C-type lectin, nucleic acid molecules encoding the binding molecules or the human C-type lectin, compositions comprising the binding molecules or the human C-type lectin and methods of identifying or producing the binding molecules. The human C-type lectin is specifically expressed on myeloid cells and binding molecules capable of specifically binding to the human C-type lectin can be used in the diagnosis, prevention and/or treatment of neoplastic disorders and diseases.
    Type: Application
    Filed: December 22, 2005
    Publication date: August 10, 2006
    Applicant: Crucell Holland B.V.
    Inventors: Sonja van den Oudenrijn, Marja van Meijer, Adrianus Bakker, Alexander Bakker